Grantham, Mayo, Van Otterloo & Co (GMO)
TCO

Grantham, Mayo, Van Otterloo & Co (GMO)’s Taubman Centers Inc. TCO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio TCO Stock Details TCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-319,070
Closed -$10.6M – 914
2020
Q3 		$10.6M Sell
319,070
-18,330
-5% -$684K 0.08% 149
2020
Q2 		$12.7M Buy
337,400
+161,673
+92% +$6.61M 0.09% 129
2020
Q1 		$7.36M Buy
+175,727
New +$7.32M 0.06% 178

Other funds holding TCO

MMEA
MEAG MUNICH ERGO AssetManagement Munich, Germany $162K AUM 21.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s TCO Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Taubman Centers Inc. (TCO) in Q4 2020, closing a stake of 319,070 shares — an estimated $10.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TCO in Q1 2020 and held it in 3 quarters. The position peaked at $12.7M in Q2 2020. 4 funds tracked by Wall St. Rank hold TCO as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Taubman Centers Inc. position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 319,070 Taubman Centers Inc. shares in Q4 2020, an estimated $10.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Taubman Centers Inc. in Q1 2020 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Taubman Centers Inc. position peaked at $12.7M in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Taubman Centers Inc. as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.